Navigation Links
Amicus in Medical News

Retail Industry Leaders Association Files Amicus in California Health Care Litigation

ARLINGTON, Va., March 31 /PRNewswire/ -- The Retail Industry Leaders Association (RILA) today filed a friend-of-the-court (amicus) brief in litigation under consideration in the United States Court of Appeals for the Ninth Circuit challenging the City of San Francisco's employer health plan ma...

CMPI to Host Hill Briefing Tomorrow on Follow-on Biologic Drugs for Media and Congressional Staff With Reps. Eshoo and Rogers

...icer, Thomas Jefferson University, and Director, Jefferson Center for Vascular Diseases; and John F. Crowley, President and Chief Executive Officer of amicus Therapeutics. All three will help highlight the importance of balancing cost reduction and the well-being of patients in the follow-on biologics debat...

Americans United for Life: Ninth Circuit Ruling on Pharmacists Endangers Fundamental Freedoms

...ral, or ethical beliefs, it is a loss for liberty and undermines the Constitution itself." AUL assisted the plaintiffs' attorney in coordinating amicus brief support and also filed a brief on behalf of nineteen Washington Senators and Representatives, arguing that the U.S. Constitution and Supreme Co...

CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers

...er, Thomas Jefferson University , and Director, Jefferson Center for Vascular Diseases; and John F. Crowley, President and Chief Executive Officer of amicus Therapeutics. All three will help highlight the importance of balancing cost reduction and the well-being of patients in the follow-on biologics debat...

Ohio Supreme Court Supports Regulation of Dangerous Abortion Drug

... decisive end to that." Americans United for Life (AUL) filed an amicus brief in the case on behalf of several U.S. Representatives supporting the State and the law. AUL's amicus brief, filed on behalf of House Minority Leader John Boehner (Ohio) and nin...

Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill'

... decisive end to that." Americans United for Life (AUL) filed an amicus brief in the case on behalf of several U.S. Representatives supporting the State and the law. AUL's amicus brief, filed on behalf of House Minority Leader John Boehner (Ohio) and nin...

Americans United for Life Applauds Fourth Circuit Protecting Women and Children by Upholding Virginia Partial Birth Abortion Statute

...at mirrors the federal ban on partial-birth abortion. Americans United for Life (AUL) provided litigation support to the state and filed an amicus brief supporting Virginia's law. In addition, AUL Senior Counsel Clarke Forsythe assisted the Solicitor General of the Commonwealth of Virginia wit...

LCA Hails US Court of Appeals Decision to Affirm Lower Court Ruling Tobacco Companies Guilty of Massive Fraud and Deception

...llow her to assess retrospective penalties. LCA joined in a subsequent amicus brief urging the appeals court to reconsider. That was denied in Friday's r...n low levels of federal research funding for lung cancer. The intent of the amicus brief was to make up for this short-fall. "Even though the Court rulin...

Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit

...his work with Celgene Corporation, Dr. Barer serves on the Board of Trustees of Rutgers University and BioNJ, on the Board of Directors of PhRMA and amicus Therapeutics, and on the Board of the Brooklyn College Foundation. He has previously served as a Commissioner of the NJ Commission on Science and Te...

Americans United for Life Represents 28 Bipartisan Montana Legislators Arguing Assisted Suicide Not a Right

...ountable. That is not assisted suicide--that is euthanasia." AUL worked in conjunction with the Montana Attorney General's office to coordinate amicus briefs supporting the State's current prohibition of assisted suicide. AUL's brief is available at http://tinyurl.com/Baxter-v-MT ...
Amicus in Medical Technology

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

...RANBURY, N.J., June 22 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced it ...s year. John F. Crowley, President and CEO of amicus stated, "The start of our Phase 3 trial with Amigal is a major milestone for amicus and highlights our transition into a late-stage de...

Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent

...CRANBURY, N.J., March 25 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced the...red by the standard endpoints in Gaucher disease. amicus previously reported that enrollment has been compl...to be available in the third quarter of 2009. amicus is developing Plicera as part of a strategic colla...

Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease

... CRANBURY, N.J., Feb. 27 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) announced today tha...rting the trial as expeditiously as possible. amicus initiated the Phase 2 clinical trial of AT2220 in ...0. After initial evaluation of the events, amicus suspended patient enrollment for the Phase 2 trial...

Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009

... CRANBURY, N.J., Jan. 12 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced pos...nt of Fabry disease in the second quarter of 2009. amicus also reviewed data on the potential for the combin...chloride) for the treatment of Fabry Disease amicus previously announced in August 2008 that it had co...

Amicus Therapeutics Announces Second Quarter 2008 Financial Results

... CRANBURY, N.J., Aug. 7 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ), a biopharmaceutical.... Generally Accepted Accounting Principles (GAAP), amicus announced a net loss attributable to common stockh...sease," said John F. Crowley, President and CEO of amicus Therapeutics. "In the second half of 2008, we will...

Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease

... CRANBURY, N.J., Aug. 4 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ), a biopharmaceutical... expected to be available by Q1 2009. In addition, amicus expects to conduct clinical pharmacology studies to support the Phase 3 program. amicus is developing Amigal as part of a strategic collab...

Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease

... CRANBURY, N.J., June 3 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ), a biopharmaceutical...irimycin HCl), for the treatment of Pompe disease. amicus will conduct the study in adult Pompe patients in ... to cause the various symptoms of Pompe disease. amicus is initiating the multi-national, open-label Phase...

Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220

...Therapy CRANBURY, N.J., March 13 /PRNewswire/ -- amicus Therapeutics, a biopharmaceutical company developi...T2220," said John F. Crowley, President and CEO of amicus Therapeutics. "Based on these data and the safety ...ingredient in AT2220 in the United States. About amicus Therapeutics ...

Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference

... CRANBURY, N.J., Jan. 2 /PRNewswire-FirstCall/ -- amicus Therapeutics Inc. (Nasdaq: FOLD ), today announce... Company's website until January 22, 2008. About amicus Therapeutics amicus Therapeutics is a biopharmaceutical company develo...

Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease

... CRANBURY, N.J., Oct. 23 /PRNewswire-FirstCall/ -- amicus Therapeutics, a biopharmaceutical company developi...sease," said John F. Crowley, President and CEO of amicus Therapeutics. About Pompe Disease Pompe disease ... ingredient in AT2220 in the United States. About amicus Therapeutics ...
Amicus in Biological Technology

Meredith Martin Addy Named Chair of AIPLA's Amicus Committee

CHICAGO, Nov. 2 /PRNewswire/ -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the United States, is pleased to announce that Meredith Martin Addy, a shareholder and chair of the firm's Appellate Group, has been appointed chair of the Amicus Committee of the...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... CRANBURY, N.J., Aug. 5 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced fin.... Generally Accepted Accounting Principles (GAAP), amicus announced a net loss attributable to common stockh...ion. John F. Crowley, President and CEO of amicus stated, "The second quarter was marked by a signif...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date

... CRANBURY, N.J., July 29 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) will announce secon...n also be accessed via the investor section of the amicus Therapeutics Web site at www.amicustherapeutics....l remain available in the Investors section of the amicus Therapeutics Web site for 30 days. Amicus'...

Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009

...CRANBURY, N.J., May 11 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced tha...tion by logging on to the Investors section of the amicus Therapeutics' Web site, http://www.amicustherap...on the Company's Web site for 30 days. About amicus Therapeutics ...

Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date

...CRANBURY, N.J., April 30 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) will announce first...n also be accessed via the investor section of the amicus Therapeutics Web site at www.amicustherapeutics....l remain available in the Investors section of the amicus Therapeutics Web site for 30 days. Amicus' p...

Shire begins the year with a strong performance

...study ongoing. HGT-3510 - for the treatment of Pompe Disease - In February 2009, the Phase 2 clinical trial for HGT-3510 initiated by amicus Therapeutics Inc. ("Amicus") was placed on clinical hold in response to reports of two serious adverse events that were probably related t...

Marinus Pharmaceuticals Raises $20 Million in Series B Financing

...f innovative companies in the digital media, communications & mobility, enterprise and clean tech industries. Among its successes are Acme Packet, amicus Therapeutics, Cerexa Inc., CommerceOne, DexCom Inc., DoubleClick, IntraLinks, Match.com, SuccessFactors and WebLoyalty. Other Canaan investments inclu...

Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference

...CRANBURY, N.J., March 30 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) today announced tha...tion by logging on to the Investors section of the amicus Therapeutics' Web site, www.amicustherapeutics.co...on the Company's Web site for 90 days. About amicus Therapeutics ...

Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting

...CRANBURY, N.J., March 28 /PRNewswire-FirstCall/ -- amicus Therapeutics (Nasdaq: FOLD ) announced today pos...ients." John F. Crowley, President and CEO of amicus Therapeutics, added, "We are very pleased with thi...econd quarter of this year." In January 2009, amicus announced that the FDA supports a Phase 3 clinical...

Publication of Shire plc's Annual Report 2008

...ely small company's future. Three deals later-with amicus Therapeutics, Inc. ('Amicus'), Zymenex A/S ('Zymen...r 2007 Shire entered into a license agreement with amicus under which it received the rights to three compou...market exclusivity in the EU. In March 2008 amicus announced positive data from its Phase 2 clinical ...
Other Tags
(Date:7/11/2014)... TX (PRWEB) July 11, 2014 Plasma ... of blood products industry. Although the closure of 16 ... major disruption to domestic blood products market, the total ... 2.8% year on year and total lot release volume ... due to stock consumption, insufficient utilization of new plasma ...
(Date:7/11/2014)... Even the hot Texas sun won’t keep ... . The school had previously invested in a ... from APCPLAY, but recently asked for an innovative solution to ... Godley Elementary School chose a Rectangular Shade from APCPLAY as ... on their playground. The shade measures 24’W x 34’H ...
(Date:7/11/2014)... Based in Pearland, Prime Urgent Care has ... County and surrounding counties. Recently, it improved access to ... from Northbound Highway 288 and Feeder Road. , Prime ... get low-cost urgent care of high quality. Although low-cost ... that can match the quality service level of the ...
(Date:7/10/2014)... July 10, 2014 Fatigue, lack ... an increasing number of accidents in the workplace, ... Reboot. The articles highlight safety issues that contribute ... million accidents occur on the job annually, according ... continue to explore "preventable workplace accidents." , Safety ...
(Date:7/10/2014)... July 11, 2014 According to ... Market by Platforms (Land, Airborne, Naval), Application (Software ... & by Geography (North America, Asia-Pacific, Europe, the ... (2014-2019)", published by MarketsandMarkets, the market is estimated ... expected to register a CAGR of 5.56% to ...
Breaking Medicine News(10 mins):Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4Health News:Cool Fun Under the Texas Sun: Godley Elementary School Purchases Shade Structure from APCPLAY© 2Health News:Prime Urgent Care Announces New Access to the Clinic, Available from Northbound Highway 288 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 4
(Date:7/10/2014)... June 27, 2014  Pomerantz LLP has filed ... ("Provectus" or the "Company")(NYSE-MKT: PVCT) and certain of ... States District Court, Middle District of ... of a class consisting of all persons or ... between December 17, 2013 and May 22, 2014, ...
(Date:7/10/2014)... July 2, 2014 It is a great ... the appointment of the world-renowned Thoracic and Cardiovascular surgeon, ... Dr. Ginsburg, with over 34 years of ... Hospital and Good Samaritan Regional Medical Center. Dr. Ginsburg ... late 1980,s and is considered an expert in the ...
(Date:7/10/2014)... , July 7, 2014 Fingerprint Cards, ... major design win (DW). A Chinese Top 5 smartphone OEM ... start of mass production in October 2014.   ... Top 5 smartphone OEM, which has a planned date for ... target sales volume for this phone of 3 million units. ...
Breaking Biology News(10 mins):SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2
Other Contents